Showing results (111-120 of 251) with videos related to

Sort By:
Pageof 26
Anticancer Research|March 8, 2019
Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung CancerKazuhisa Nakashima, Hiroaki Akamatsu, Haruyasu Murakami, et al.
Asia-Pacific Journal of Oncology Nursing|April 14, 2021
Days Spent at Home near the End of Life in Japanese Elderly Patients with Lung Cancer: Post hoc Analysis of A Prospective StudyMikako Notsu, Tateaki Naito, Keita Mori, et al.
Medical Oncology (Northwood, London, England)|September 26, 2009
Actual status of adjuvant chemotherapy for non-small-cell lung cancer at one Japanese cancer center: the need for increased cooperation between medical oncologists and surgeonsTakehito Shukuya, Toshiaki Takahashi, Akihiro Tamiya, et al.
International Journal of Clinical Oncology|March 4, 2010
Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancerAkira Ono, Tateaki Naito, Haruyasu Murakami, et al.
Internal Medicine (Tokyo, Japan)|June 3, 2014
Perianal metastasis of non-small cell lung cancerHisao Imai, Kenji Inafuku, Kazushige Wakuda, et al.
Cancer Science|May 5, 2016
Rebiopsy for patients with non-small-cell lung cancer after epidermal growth factor receptor-tyrosine kinase inhibitor failureTakahisa Kawamura, Hirotsugu Kenmotsu, Tetsuhiko Taira, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011)Ikuo Sekine, Hideyuki Harada, Noboru Yamamoto, et al.
Asia-Pacific Journal of Oncology Nursing|June 30, 2026
Feasibility and safety of combined touch care and aromatherapy in hospitalized patients with thoracic malignancies: A prospective single-arm studyEiko Tamai, Yumi Oguma, Akifumi Notsu, et al.
Anticancer Research|May 18, 2012
Prognostic factors and clinical outcome of patients with lung adenocarcinoma with carcinomatous meningitisYukiko Nakamura, Toshiaki Takahashi, Asuka Tsuya, et al.
Molecular Cancer Therapeutics|March 16, 2019
TAS-121, A Selective Mutant EGFR Inhibitor, Shows Activity Against Tumors Expressing Various EGFR Mutations Including T790M and Uncommon Mutations G719XKimihiro Ito, Makoto Nishio, Masanori Kato, et al.
Pageof 26